First Trust Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225M Buy
640,120
+155,930
+32% +$55.6M 0.16% 159
2025
Q4
$158M Sell
484,190
-4,591
-0.9% -$1.46M 0.12% 214
2025
Q3
$138M Sell
488,781
-46,048
-9% -$13.4M 0.1% 236
2025
Q2
$149M Sell
534,829
-21,347
-4% -$6.05M 0.12% 198
2025
Q1
$173M Buy
556,176
+93,988
+20% +$27.8M 0.15% 159
2024
Q4
$120M Sell
462,188
-102
-0% -$30.3K 0.11% 231
2024
Q3
$149M Buy
462,290
+56,817
+14% +$18.6M 0.14% 179
2024
Q2
$127M Sell
405,473
-104,784
-21% -$30.8M 0.13% 188
2024
Q1
$145M Sell
510,257
-81,554
-14% -$23.9M 0.15% 171
2023
Q4
$170M Sell
591,811
-81,959
-12% -$22.3M 0.19% 160
2023
Q3
$181M Sell
673,770
-730,045
-52% -$182M 0.21% 137
2023
Q2
$312M Buy
1,403,815
+21,872
+2% +$5.08M 0.35% 45
2023
Q1
$334M Buy
1,381,943
+88,455
+7% +$21.7M 0.39% 39
2022
Q4
$340M Sell
1,293,488
-32,683
-2% -$8.76M 0.4% 32
2022
Q3
$299M Buy
1,326,171
+3,939
+0.3% +$955K 0.39% 33
2022
Q2
$322M Sell
1,322,232
-130,872
-9% -$32.1M 0.4% 28
2022
Q1
$351M Sell
1,453,104
-160,600
-10% -$36.9M 0.36% 40
2021
Q4
$363M Buy
1,613,704
+898,059
+125% +$190M 0.35% 46
2021
Q3
$152M Sell
715,645
-568,039
-44% -$131M 0.16% 161
2021
Q2
$313M Buy
1,283,684
+106,480
+9% +$26.2M 0.34% 45
2021
Q1
$293M Sell
1,177,204
-43,877
-4% -$10.5M 0.35% 43
2020
Q4
$281M Buy
1,221,081
+160,041
+15% +$36.9M 0.37% 48
2020
Q3
$270M Buy
1,061,040
+45,797
+5% +$11.3M 0.43% 39
2020
Q2
$239M Sell
1,015,243
-30,868
-3% -$7.04M 0.42% 35
2020
Q1
$212M Buy
1,046,111
+194
+0% +$42.4K 0.48% 27
2019
Q4
$252M Sell
1,045,917
-16,474
-2% -$3.63M 0.43% 28
2019
Q3
$206M Sell
1,062,391
-134,317
-11% -$25.8M 0.39% 33
2019
Q2
$221M Buy
1,196,708
+325,404
+37% +$58.3M 0.42% 30
2019
Q1
$166M Buy
871,304
+193,914
+29% +$37M 0.33% 41
2018
Q4
$132M Sell
677,390
-13,954
-2% -$2.72M 0.31% 45
2018
Q3
$143M Buy
691,344
+224,916
+48% +$44.3M 0.27% 60
2018
Q2
$86.1M Sell
466,428
-143,183
-23% -$25.3M 0.18% 112
2018
Q1
$104M Sell
609,611
-20,572
-3% -$3.78M 0.24% 75
2017
Q4
$110M Buy
630,183
+75,135
+14% +$13.3M 0.26% 68
2017
Q3
$103M Buy
555,048
+123,641
+29% +$21.9M 0.27% 61
2017
Q2
$74.3M Buy
431,407
+80,852
+23% +$13.2M 0.2% 104
2017
Q1
$57.5M Sell
350,555
-138,147
-28% -$23M 0.16% 120
2016
Q4
$71.5M Buy
488,702
+191,048
+64% +$28.8M 0.21% 74
2016
Q3
$49.7M Sell
297,654
-41,505
-12% -$7.02M 0.15% 127
2016
Q2
$51.6M Sell
339,159
-143,055
-30% -$22.2M 0.16% 115
2016
Q1
$72.3M Sell
482,214
-308,362
-39% -$45.8M 0.23% 81
2015
Q4
$128M Sell
790,576
-130,282
-14% -$20.5M 0.33% 50
2015
Q3
$127M Buy
920,858
+2,365
+0.3% +$373K 0.37% 35
2015
Q2
$141M Sell
918,493
-188,722
-17% -$30.2M 0.37% 42
2015
Q1
$177M Buy
1,107,215
+219,864
+25% +$34.6M 0.52% 16
2014
Q4
$141M Buy
887,351
+94,300
+12% +$14.7M 0.48% 13
2014
Q3
$111M Buy
793,051
+126,556
+19% +$16.5M 0.44% 22
2014
Q2
$78.9M Buy
666,495
+56,724
+9% +$6.57M 0.33% 33
2014
Q1
$75.2M Sell
609,771
-21
-0% -$2.55K 0.33% 37
2013
Q4
$69.6M Buy
609,792
+136,703
+29% +$15.6M 0.34% 32
2013
Q3
$53M Buy
473,089
+18,064
+4% +$1.96M 0.29% 47
2013
Q2
$44.9M Buy
+455,025
New +$47.2M 0.29% 49

Other funds holding AMGN

First Trust Advisors's AMGN Position: Q1 2026 in Review

First Trust Advisors increased its Amgen (AMGN) stake by 32% in Q1 2026, buying an estimated $55.6M and bringing the position to 640,120 shares worth $225M. The position accounts for 0.16% of the portfolio, ranked #159.

First Trust Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $363M in Q4 2021. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • First Trust Advisors held 640,120 shares of Amgen worth $225M as of Q1 2026.
  • First Trust Advisors bought 155,930 Amgen shares in Q1 2026, an estimated $55.6M.
  • Amgen made up 0.16% of First Trust Advisors's portfolio in Q1 2026, its #159 holding.
  • First Trust Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • First Trust Advisors's Amgen position peaked at $363M in Q4 2021.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.